- Benchmark ASINB0FDR7TNN7
- MarketplaceUS
- Category ID8627079011
- Analyzed Products
- Keywordhome health
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-25
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，且对大品牌和小商家都不友好。 现有数据里没有任何可验证的新品牌成功样本，新品牌成功率是 0%，整体新发布盈利率也是 0%；样本虽少，但已经足够说明这里不是“靠策略就能轻松切入”的市场，而是低差异化、低利润、低成功率的盘面。
证据很直接：RLEXIO 作为当前可见的老品牌，2 个可识别产品全部不盈利，其中 B0FDR7TNN7 月销约 50 单、月营收约 461 美元，利润率只有 11.9%，已经贴近价格战边缘；B0GSQTYSV7 这个新发布款更是直接没有有效销量，属于新上架也跑不动。 产品成功/失败原因也一致：两个样本都被判定为“缺乏独特性、市场小或竞争极强、利润不够好”，说明这个类目不是靠基础铺货能做起来的，必须有明显功能差异、设计差异或更强品牌力才可能勉强推进；但按当前盘面，连老品牌都没有跑出稳定盈利，更谈不上给小商家留空间。用户预算 500000 CNY 虽然足以覆盖单个 ASIN 的启动成本，但在这里不足以改变市场结构，因为真正的障碍不是首批采购，而是后续品牌、研发和竞争压制。
- 大品牌结论：不建议进入。 当前没有看到可复制的高利润样本，也没有出现足以说明市场增长的盈利新款，反而是持续亏损和零成功率。可参考的品牌只有 RLEXIO，但它的表现更像失败样本，不是入场模板。
- 小商家结论：更不建议进入。 没有任何真实小商家成功案例，且没有低于 300 评价的有效成功样本可借鉴；在这种产品高度同质化的类目里，小商家几乎只能靠更激进的营销手段硬推，风险很高。
- 关键判断：市场已经接近价格战区，不是可正常切入的机会。 如果要硬做，必须具备明显产品升级、差异化设计或渠道优势；否则这不是机会盘，而是消耗预算盘。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing结论：不适合进入，这个市场对新卖家和小卖家都不友好。 目前能看到的信号是：利润不稳、销量弱、且新入场的老品牌也做不出结果；按你给的规则，这不是一个值得推进的市场。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?100.00%New listing success rate (old brands):0.00%Alternatives- 更便宜的第三方通用电极片补充装：只买替换贴片，不买带线套装；如果用户原有导线还能用，这通常是最低成本的替代方案。
- 在药店/连锁健康用品店购买本地通用TENS电极贴：价格可能略高于线上低价款，但更容易即时买到，适合急用或不想等配送的人。
- 选择更大包装的无品牌或白牌电极片：单片成本通常更低，适合长期频繁使用、以降低复购成本。
- 购买可剪裁/可重复使用的通用凝胶电极片：虽然初始感受不如专用预切款方便，但对不同机型和身体部位的适配更灵活，且往往更省钱。
- 直接更换单独导线而不是整套购买：如果问题主要出在线材损耗，单买导线比购买“电极片+导线”组合更经济，也更容易在现有设备上继续使用。
- 改用一次性理疗耗材的低门槛替代方案，例如热敷贴/冷敷贴：不依赖设备兼容性，使用门槛低，适合临时缓解肌肉酸痛而不想折腾配件匹配的用户。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入。核心故事很清楚：新品牌几乎没有成功样本，整体利润和新发布成功率都接近 0%，而且已有品牌也没有形成可复制的盈利模型。 这不是一个“靠努力就能切入”的市场，更像是低利润、低成功率的死胡同；不管是大品牌还是小商家，直接下场都不划算。
证据非常硬：市场可识别利润产品中，整体盈利比例 0.00%，新发布产品盈利比例 0.00%；RLEXIO 这个老品牌有 2 个可识别产品，0 个盈利，成功率 0.00%，其中 ASIN B0FDR7TNN7 月销约 50 单、月营收 461 美元，利润率只有 11.9%，但仍被判定为不盈利，说明这条线已经很接近价格战边缘。 更重要的是，B0GSQTYSV7 这个新发布款直接是无有效销量、无可见收入、非盈利，说明新切入并没有跑通；按你的规则，<10% 成功率就是高风险市场，这里是 0%。从趋势看，2026 年只看到新发布非盈利产品出现，没有看到任何盈利新款抬头，说明不是在变好，而是在继续走弱。
Old brand with the most profitable new productsRLEXIO
Recent Monthly Revenue (USD):-(-)B0GSQTYSV7Brand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$461.00(50pcs/month)B0FDR7TNN7 (4.5/5 (241 Reviews))Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0GSQTYSV7Brand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FDR7TNN7 (4.5/5 (241 Reviews))Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：只有2个可识别产品，当前样本里没有任何可验证的高利润新品牌，反而是老品牌RLEXIO的新上架产品 B0GSQTYSV7 直接亏损、且销售不活跃，市场更像是低差异化+低利润的死水区，而不是能靠小预算切入的机会。 你的预算是500,000 CNY，看起来很大，但在这里并不能换来确定性，因为真正能跑出来的不是“便宜可复制”的生意，而是需要更强品牌/研发投入的产品；对小商家来说，这个盘面不是自然成功市场。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0FDR7TNN7RLEXIO2025-07-01No$9.2250pcs$461.011.9%$54.86B0GSQTYSV7RLEXIO2026-03-16No$--pcs$--%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0GSQTYSV7RLEXIO2026-03-16No$--pcs$--%$-#New Product Success Rates
Listing这不是一个适合进入的市场：整体盈利率为0%，新上架产品盈利率也为0%，而且现有样本里没有任何真正跑通的新品案例。更糟的是，当前看到的两个样本都来自同一品牌 RLEXIO，全部亏损，说明这个细分里已经是明显的价格战+低差异化状态；用户的 50万人民币预算即使足够做单个ASIN启动，也不足以改变这种竞争结构。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
RLEXIO#Success Rate by Entry Time
Listing这个市场不值得进入：它已经是零利润、零成功的新品牌市场，且现有可见样本显示完全没有新品牌可借鉴的真实成功案例。 用户预算 500000 CNY 看起来不低，但在这个类目里不是钱够不够的问题，而是市场本身已经把新进入者挤到失败区间了。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 1 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases